NDC 86136-139 - OstiLox
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86136-139
- Package NDCs from labels
- 86136-139-31, 86136-139-69
- Manufacturer
- MWI/Vetone | FELIX PHARMACEUTICALS PRIVATE LIMITED
- Effective date
- 2025-07-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OstiLox - MWI/Vetone | FELIX PHARMACEUTICALS PRIVATE LIMITED | MWI/Vetone | FELIX PHARMACEUTICALS PRIVATE LIMITED | 2025-07-29 | Prescription Animal Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86136-139-31 | OstiLox | 10 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 10 | 1 | |
| 86136-139-31 | OstiLox | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 | |
| 86136-139-69 | OstiLox | 20 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 20 | 1 | |
| 86136-139-69 | OstiLox | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| meloxicam | MELOXICAM | Bryant Ranch Prepack | 3e37bece-b23e-41ca-9557-5105087e273b | 2024-08-08 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Lupin Pharmaceuticals, Inc. | 06a401f0-4380-4081-86ed-a309a25abf6b | 2024-08-08 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Unichem Pharmaceuticals (USA), Inc. | 5fe76337-eae5-4e5c-96ef-6cfa97983c6e | 2024-08-05 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | NuCare Pharmaceuticals, Inc. | 4925f194-c924-242c-e054-00144ff88e88 | 2024-07-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | NuCare Pharmaceuticals,Inc. | 630221ef-714e-6996-e053-2991aa0a586f | 2024-07-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | Proficient Rx LP | 3cc9741f-0574-485f-bbf5-027cb236736c | 2024-06-01 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | AiPing Pharmaceutical, Inc | f93806e1-88b8-4bcd-ac29-7642ab4d6cbd | 2024-05-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | A-S Medication Solutions | eb5834e0-c6db-4d0f-ae37-9ba2e1aabfdf | 2023-11-26 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | A-S Medication Solutions | bcfca8c6-bdba-4546-97be-1fc5601c7346 | 2023-09-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | NCS HealthCare of KY, LLC dba Vangard Labs | 108397e9-672d-4061-bb74-65818c782d61 | 2023-03-07 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Asclemed USA, Inc. | 49367275-4bff-4e36-8a91-e59eb07aa15f | 2022-10-05 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | e1603665-bbce-48b3-9424-3646570ae9b8 | 2022-08-17 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Proficient Rx LP | b5d72a30-3d32-45ad-be81-3fe601d8912b | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 432c3937-a4fe-4c92-8452-9ed2dd2cfc9a | 2022-03-03 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 9392df66-a152-40e6-b43b-44dc46a23496 | 2021-08-10 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 10c3949c-0066-4b8a-8d35-937e1ce09bf8 | 2021-08-06 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 8f43b954-d1cb-4210-b479-5292c446cc74 | 2021-05-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 966ae650-ad7d-4de1-ab06-54992408fcfd | 2021-03-11 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 2a29daa9-74e5-4ed6-b5f1-ce04dc411b26 | 2020-07-20 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Exelan Pharmaceuticals Inc. | dfaac71c-dcc5-4b57-bf3b-616fccab96de | 2018-09-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.